Results 131 to 140 of about 88,035 (207)

Efficacy of Triple Therapy with Proton Pump Inhibitor, Levofloxacin and Amoxicillin as First Line Treatment to Eradicate Helicobacter Pylori: An Observational Study

Mohammad Asadur Rahman, Mahedi Hasan, ABM Safiullah, Mohammad Shoaib Chowdhury, Mohammad Syedul Islam, Ahmad Monjurul Aziz, Rana Jahangir Alam, Khalada Binte Khair   +7 more
openalex   +1 more source

Zinc oxide resveratrol nanoparticles ameliorate levofloxacin-induced hepatotoxicity in rat model. [PDF]

BMC Pharmacol Toxicol
Zaki NF, Orabi SH, Abdel-Bar HM, Korany RM, AlShuraym LA, Alkeridis LA, Ahmed MM.   +6 more
europepmc   +1 more source

Pharmacokinetics (PK) of aerosol MP-376 (aeroquin; levofloxacin inhalation solution) in CF patients

, 2010
David E. Geller, Patrick A. Flume, David C. Griffith, Erin Morgan, Dan White, J. Loutit, Michael N. Dudley   +6 more
openalex   +1 more source

High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand [PDF]

, 2015
Hatainuch Prapitpaiboon, Varocha Mahachai, Ratha‐Korn Vilaichone   +2 more
openalex   +1 more source

Revealing the molecular mechanisms of levofloxacin-induced cognitive impairment and epilepsy: an integrated bioinformatics and molecular dynamics simulation. [PDF]

BMC Pharmacol Toxicol
Zhang Y, Wu Y, Du J, Chen J, Yu H, Yang K, Huang F, Xie J, Peng J.   +8 more
europepmc   +1 more source

Reply to Liao <i>et al.</i>: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. [PDF]

Am J Respir Crit Care Med
Phillips PPJ, Peloquin CA, Sterling TR, Mitnick CD, Horsburgh CR.   +4 more
europepmc   +1 more source

Open Label Observational Comparative Efficacy Study of Ceftriaxone and Levofloxacin in COPD Exacerbations [PDF]

, 2016
Veintramuthu Sankar, Kanaka Durga, Krishna Priya, Sonymol Jose, Rinku Mary Joseph, Pinky Mariyam Thomas   +5 more
openalex   +1 more source

RETRACTION: Acute Pancreatitis Associated with the Antibiotic Levofloxacin: A Rare Case Report. [PDF]

Clin Case Rep
europepmc   +1 more source

Development of a novel ultrashort antimicrobial peptide-levofloxacin conjugate with enhanced synergistic activity against multidrug and levofloxacin-resistant bacterial isolates. [PDF]

Res Pharm Sci
Almaaytah A, Alrashdan A, Sabi SH.
europepmc   +1 more source

Correlation between GyrA Substitutions and Ofloxacin, Levofloxacin, and Moxifloxacin Cross-Resistance in Mycobacterium tuberculosis [PDF]

, 2015
Melisa J. Willby, R. David Sikes, Seidu Malik, Beverly Metchock, James E. Posey   +4 more
openalex   +1 more source